— Flagship Service · Specialist-led

Structured Deprescribing

For people who want to reduce or stop long-term psychiatric medication — safely, gradually, and with full consultant oversight. This is not about stopping abruptly. It is a careful, medically supervised process built entirely around you.

Regulated & Accredited
GMC Registered FRCPsych · MRCPsych CQC Regulated RCPsych Member ICO Data Protection

⸺ Common misconceptions

What deprescribing is — and what it isn’t

Many patients arrive carrying fears and assumptions about reducing medication. Let us address them honestly.

Common belief

Stopping medication means going cold turkey and risking serious withdrawal.

The reality

Structured deprescribing is gradual, supervised, and planned — withdrawal risk is carefully managed at every step.

Common belief

If medication was prescribed, it must still be needed.

The reality

Many prescriptions are never reassessed. A thorough review often reveals that needs — and better options — have changed.

Common belief

Wanting to reduce medication means rejecting psychiatry or going against medical advice.

The reality

Requesting a medication review is a medically valid and increasingly supported clinical decision.

Common belief

If I reduce medication, my original symptoms will come back worse than before.

The reality

With proper support and a bespoke taper plan, most people reduce successfully without relapse when timing and pace are right.

How our deprescribing process works

Every step is consultant-led, documented, and adapted to your individual clinical picture. There is no one-size-fits-all timeline.

01

Initial Psychiatric Assessment

A comprehensive, unhurried consultation covering your full psychiatric history, current medication, reasons for wanting to reduce, lifestyle context, and goals.

60–90 minute video or in-person consultation. Full clinical notes provided. No pressure to proceed if the assessment suggests this is not the right time.

02

Bespoke Taper Plan

A personalised, medically guided tapering schedule accounting for your specific medication, dosage, duration of use, nervous system sensitivity, and life circumstances.

Written plan provided. Hyperbolic tapering where indicated. Timing built around your life — not a generic protocol.

03

Supported Reduction Phase

Regular check-in appointments to monitor progress, adjust the plan as needed, and address any emerging symptoms before they become problematic.

Frequency tailored to your needs. Clear escalation pathway if symptoms worsen. Flexibility to pause or slow at any point.

04

Stabilisation & Discharge

Once at your target dose or off medication, we support a consolidation period — ensuring changes are stable before transitioning to independent management.

Shared care letter where appropriate. Long-term self-management guidance. Optional follow-up sessions available.

Medications we support in our
deprescribing programme

We review a broad range of psychiatric medications. All reviews follow clinical evidence and prioritise your safety above all else. Suitability is always assessed individually before any taper plan is created.

Not all medications are suitable for deprescribing in all circumstances. The complexity indicators below reflect the level of clinical monitoring typically required — not a value judgement about the medication itself.
01

Antidepressants

Antidepressants

SSRIs SNRIs TCAs MAOIs

Including long-term use of sertraline, fluoxetine, venlafaxine, and citalopram. Particular expertise in managing discontinuation syndrome through gradual, hyperbolic taper protocols.

Monitoring
02

Antipsychotics

Antipsychotics

Typical Atypical Depot

Including quetiapine, olanzapine, risperidone, and aripiprazole. Requires careful monitoring — suitability is assessed thoroughly before proceeding, with close attention to original indication.

Monitoring
03

Mood Stabilisers

Mood Stabilisers

Lithium Valproate Lamotrigine

Review only where clinically appropriate and where the original diagnosis has been thoroughly reassessed. Requires careful shared decision-making and robust monitoring throughout.

Monitoring
04

Sedatives & Hypnotics

Sedatives & Hypnotics

Benzodiazepines Z-drugs

Including diazepam, lorazepam, zopiclone, and zolpidem. High dependency potential means structured taper protocols are essential — self-managed reduction is not recommended.

Monitoring
05

ADHD Medication

ADHD Medication

Stimulants Non-stimulants

Including methylphenidate, lisdexamfetamine, and atomoxetine. Always reviewed in the context of a full neurodiversity assessment to ensure the original diagnosis remains accurate.

Monitoring
06

Polypharmacy

Complex Regimens

Polypharmacy Multiple medications

Many patients arrive on multiple medications prescribed over many years. We have experience rationalising complex regimens safely and collaboratively, one step at a time.

Monitoring
⸺ Is this right for you?

This service may be right for you if…

This may not be the right fit if…

— You are in acute psychiatric crisis or require emergency care

— You want rapid medication changes without careful assessment and planning

— You are unwilling to maintain regular follow-up during the reduction process

All reviews independently verified
Ready to explore a safe medication review?

Book an initial consultation and we will assess whether structured deprescribing is appropriate for you — without pressure and with complete transparency.

All deprescribing decisions are made collaboratively, following a full psychiatric assessment.